NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.270
+0.010 (0.79%)
Mar 11, 2026, 4:00 PM EDT - Market closed

NovaBay Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
3.24-7.22-9.64-10.61-5.82-11.04
Depreciation & Amortization
0.010.040.050.480.120.05
Stock-Based Compensation
0.020.150.290.221.150.75
Other Adjustments
-9.082.455.472.72-4.65.3
Change in Receivables
-0.050.290.85-0.310.45-0.32
Changes in Inventories
-0.53-0.270.16-0.22-0.24-0.12
Changes in Accounts Payable
0.51-0.2-1.130.67-0.16-0.32
Changes in Other Operating Activities
-0.3-0.42-0.310.39-0.080.32
Operating Cash Flow
4.02-5.26-4.13-6.65-9.19-4.72
Capital Expenditures
-0-0.01-0.02-0.11-0.05-0.03
Payments for Business Acquisitions
-----11.99-
Proceeds from Business Divestments
-1.07----
Investing Cash Flow
-01.06-0.02-0.11-12.05-0.03
Short-Term Debt Issued
----0.11-
Short-Term Debt Repaid
----0.11--
Net Short-Term Debt Issued (Repaid)
----0.110.11-
Long-Term Debt Issued
-0.53---
Long-Term Debt Repaid
-0.76-1.99-1.47---2.56
Net Long-Term Debt Issued (Repaid)
-0.76-1.491.53---2.56
Issuance of Common Stock
1.173.110.571.71.7812.33
Repurchase of Common Stock
-1.99-----
Net Common Stock Issued (Repurchased)
-0.823.110.571.71.7812.33
Issuance of Preferred Stock
---3.0414.91-
Net Preferred Stock Issued (Repurchased)
---3.0414.91-
Other Financing Activities
--0.12-0.18---
Financing Cash Flow
-2.71.51.914.6316.799.76
Net Cash Flow
1.45-2.7-2.24-2.13-4.455.02
Free Cash Flow
4.02-5.27-4.15-6.77-9.24-4.75
FCF Margin
39.18%-53.87%-39.69%-46.97%-90.59%-47.79%
Free Cash Flow Per Share
2.88-7.76-172.92-735.43-1297.27-828.93
Levered Free Cash Flow
9.84-10.95-16.69-15.16-6.88-13.69
Unlevered Free Cash Flow
-2.03-6.69-5.35-13.21-9.29-6.51
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q